PP_1170x120_10-25-21

AdhereHealth launches COVID-19 Adherence Solution

Print Friendly, PDF & Email

NASHVILLE, Tenn. — AdhereHealth announced on Tuesday the immediate availability of its new COVID-19 Adherence Solution, an innovative program that combines comprehensive predictive analytics and tech-enabled consumer outreach with home-delivered pharmacy services to support the Coronavirus crisis response.

COVID-19 has exacerbated existing social determinant of health (SDOH) issues and medication adherence challenges for underserved populations. Statistics show almost 90% of those who are hospitalized with the virus have underlying conditions, and a majority are over the age of 50.

“There’s real-world evidence that shows medication non-adherence is driving more COVID-19 hospitalizations,” said Jason Rose, CEO of AdhereHealth. “By proactively targeting high-risk populations we can help keep more consumers adherent and healthy, and reduce the risk of becoming seriously ill from the virus.”

AdhereHealth’s COVID-19 Adherence Solution program helps improve health outcomes for at risk populations by enabling health plans and employers with:

• Comprehensive predictive analytics to identify populations at higher risk of medication non-adherence

•  Support from a team of nationwide employed licensed clinicians who provide direct omni-channel consumer and provider engagement to discuss health status and coordinate care

• Data-driven outreach designed to resolve SDOH issues in the context of COVID-19 using available health plan benefits and community resources

• Private-couriered medication delivery services catering to vulnerable populations

“In normal times, a staggering 50% of patients who are managing chronic conditions don’t take their medications as directed. Factor in continued lockdowns, social distancing and economic hardships  – and it’s easy to see how non-adherence is likely to get worse. Engaging with consumers proactively gives us a chance to get them support before they wind up in a hospital bed.”


ECRM-08-202222

Adheris Health

Comments are closed.

Adheris Health